Navigation Links
NewCardio Announces Master Services Agreement With Dedicated Phase I
Date:8/5/2009

his agreement demonstrates the firm's commitment to the use of technology to improve quality and efficiency."

This Master Services Agreement is part of a transition from semi-automated methods to more advanced, higher quality, and more efficient methodologies made possible for the first time through the use of NewCardio's QTinno(TM) solution.

NewCardio's innovative 3D ECG platform technology dramatically improves the accuracy and significantly increases the diagnostic value of the standard 12-lead electrocardiogram (ECG). NewCardio's lead product is QTinno(TM), a software suite that provides an automated, comprehensive analysis of QT intervals and other ECG-based cardiac safety for the pharmaceutical industry and drug regulators. The Company believes that its QTinno(TM), software-based, analytical technology is the industry's first solution for the reliable automated analysis of ECGs used to determine cardiac toxicity during drug development.

About NewCardio, Inc.

NewCardio is a cardiac diagnostic and services company focused on the development of a proprietary platform technology to provide higher accuracy to, and increase the value of, the standard 12-lead electrocardiogram (ECG). NewCardio's development-stage software and hardware products and services are intended to improve the diagnosis and monitoring of cardiovascular disease (CVD), as well as cardiac safety assessment of drugs under development. NewCardio's three-dimensional ECG platform is designed to reduce the time and expense involved in assessing cardiac status while increasing the ability to diagnose clinically significant conditions which were previously difficult to detect. For more information, visit www.newcardio.com.

Forward-Looking Statements

This press rele
'/>"/>

SOURCE NewCardio, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. NewCardio Leadership to Present Two Abstracts at ISCE Conference
2. Vincent W. Renz Joins NewCardio as President
3. NewCardio Announces Positive Results From Third Clinical Validation Study
4. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
5. Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets In Patients With Myelodysplastic Syndrome
6. Cryo-Cell Announces Celle(SM) Research and Development Collaboration with Cryopraxis Cryobiology Ltd.
7. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
8. Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma
9. Cardica Announces Publication of Pivotal PAS-Port(R) Proximal Anastomosis System Clinical Trial Results
10. Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing
11. AlphaVax Announces Results from Initial Testing of Its H1N1 (Swine) Influenza Vaccine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ovalsoftwonewtherapiesforNon-Hodgkin,sLymphomas(NH...ofatumumab(Azerra(TM),GlaxoSmithKline)asatherapyop...andromidepsin(Istodax(R),GloucesterPharmaceuticals...lllymphoma(CTCL). ,, FORTWASHINGTON,Pa.,Nov.23/...romptedtheNationalComprehensiveCancerNetwork( NCCN...
(Date:11/23/2009)...wswire/--Reportlinker.comannouncesthatanewmarketre...thesiaDisposables-AWorldMarketReview ,, http...ables---A-World-Market-Review.html#utm_source=prne...re ,, Globalgeneralanesthesiadisposablesmar...etheconsiderablerisewitnessedingeneralsurgicalproc...
(Date:11/23/2009)...Nov.23/PRNewswire-FirstCall/-- LexiconPharmaceutic...edatafromitsPhase2clinicalstudywith LX1031 inpatie...willbepresentedatGASTRO2009inLondonthisweek.Result...IBSsymptoms,willbepresentedbyDr. PhilipM.Brown ,Le...November25,2009at2:30pmlocaltimeatthesessionentitl...
Breaking Medicine Technology:NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 2NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 3Reportlinker Adds Anesthesia Disposables - A World Market Review 2Reportlinker Adds Anesthesia Disposables - A World Market Review 3Reportlinker Adds Anesthesia Disposables - A World Market Review 4Reportlinker Adds Anesthesia Disposables - A World Market Review 5Reportlinker Adds Anesthesia Disposables - A World Market Review 6Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Stem Cell Decision Opens New Doors May Spur More Research 51762 1Stem Cell Decision Opens New Doors May Spur More Research 51762 2Stem Cell Decision Opens New Doors May Spur More Research 51762 3Watson Confirms Filing of Abbreviated New Drug Application for Generic Sanctura XR 28R 29 51761 1Watson Confirms Filing of Abbreviated New Drug Application for Generic Sanctura XR 28R 29 51761 2Menopause Is More Than A Hot Flash 51759 1Menopause Is More Than A Hot Flash 51759 2Menopause Is More Than A Hot Flash 51759 3Menopause Is More Than A Hot Flash 51759 4
... Data Show Significant Improvements With ROX-828 I...Up to 48 Hours Vs. Placebo, MENLO PARK, Calif., A...ve top-line data from a clinical study of the comp...er in the treatment of migraine,and related sympto...y evaluated the efficacy,and safety of ROX-828, an...
...tion of Phase IIa Efficacy Results, LAUSANNE, Swi... a global independent biopharmaceutical developmen...s, particularly oncology, presented,positive effic... selective,cyclophilin (Cyp) inhibitor with a pote...ect. Data indicates that Debio 025 shows an,import...
Other Medicine Technology:ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment 2ROXRO PHARMA Announces Positive Clinical Proof of Concept Results for Novel Intranasal Migraine Treatment 3Clinical Update - Debio 025 in Hepatitis C 2Clinical Update - Debio 025 in Hepatitis C 3
(Date:11/23/2009)...er of patients who reined in their hypertension, s...Day News) -- High blood pressure is better control...d than by doctors and pharmacists working alone, a...pharmacists, medications are intensified, dosages ...d Barry L. Carter, a professor in the University o...
(Date:11/23/2009)...MinorityBanksin Washington D.C. , NewYorkCit...toSpurEconomicGrowthandRevitalization ,, WASHI...enation,sleadingproviderofdialysisservices,todaywa...unityfora$1millioninvestmentinIndustrialBankaspart...s. ,, DaVita,sinvestmentinWashington,D.C.ispart...
(Date:11/23/2009)...caretofinance"reform"isamoraloutrage ,, WASHI...eDemocratsmovedforwardtobeginthedebateontheirhealt...pporterstronggrassrootssenioradvocacygroup,iscalli...testthemassivecutstoMedicare.RetireSafePresidentTh...issuesliketaxes,abortion,andimmigration,whilethesi...
(Date:11/23/2009).../PRNewswire-USNewswire/-- The AmericanLegislative...lmembershipassociationofstatelegislators,congratul...re-filinga constitutionalamendment toprotecttherig...thCarolinanowbecomesthe24thstatewherelegislatorsha...erALEC,s FreedomofChoiceinHealthCareAct . ,, (L...
(Date:11/23/2009)...ov.23/PRNewswire/--InasurveyofNewJerseyandPhiladel...lOfficers,72percentdonotbelieveanewhealthcarebillw...ccordingtoresultsofthelatestsurveyconductedbytheAl...heeconomytoppedthelistat85percentasthebiggestnatio...surveyssenttocompaniesfromallpartsofNewJerseyandSo...
Breaking Medicine News(10 mins):Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 2Health News:Doctor-Pharmacist Teams Boost Blood Pressure Control 3Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 2Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 3Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 4Health News:RetireSafe Calls on Seniors to Grab their Bullhorns to Save Medicare from Rationed Care 2Health News:South Carolina Now 24th State to Defend Health Care Choice 2
... be available for vegetarians. It is possible to p...s, from the cells taken from cow, chicken, pig, fi...imal would not only reduce the need for the animal...ed to be healthier than farm raised meat, while sa...
... affected at least 20 deployed to fight Maoist ext...n said Saturday. The state government has deplo...olice // in three villages of Sambalpur district w...water," said Raju Barali, who is suffering from ma...
...School of Medicine had reported that a key process.... These are unique cells that are unusual because ...ientists long have thought the transformation of p...sor cell that forms platelets and platelets isolat...
...ic images have been known to cause momentary perio... there are limits to how much information people c...a consequence of this, we often miss visual images...so miss what we are searching for if we are shown ...
...rsity of Washington, Seattle, and colleagues, have...eimer’s disease. Moderately elevated levels of in...and beta-amyloid // in plasma and in cerebrospinal...rs, the investigators raised blood insulin levels ...
...r Biology (CCMB), Hyderabad has unraveled the myst...cting the mechanisms that prevent cancer in human ...d Utpal Bhadra have been instrumental behind this ...tin), which are responsible for rapid cell divisio...
Other Medicine News:
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
...s a national reference laboratory and a worldwide ...opment. ARUP offers an extensive test menu of high...d anatomic pathology. Owned by the University of U...half of the nation's university teaching hospitals...
Medicine Products: